Knoll Pharmaceutical Co. v. Automobile Insurance

167 F. Supp. 2d 1004, 2001 U.S. Dist. LEXIS 16382, 2001 WL 1195726
CourtDistrict Court, N.D. Illinois
DecidedOctober 5, 2001
Docket00 C 6733
StatusPublished
Cited by13 cases

This text of 167 F. Supp. 2d 1004 (Knoll Pharmaceutical Co. v. Automobile Insurance) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Knoll Pharmaceutical Co. v. Automobile Insurance, 167 F. Supp. 2d 1004, 2001 U.S. Dist. LEXIS 16382, 2001 WL 1195726 (N.D. Ill. 2001).

Opinion

MEMORANDUM OPINION AND ORDER

CASTILLO, District Judge.

Knoll Pharmaceutical Company (“Knoll”) filed this diversity lawsuit, seeking a declaration that Automobile Insurance Company of Hartford (“Automobile”), National Union Fire Insurance Company of Pittsburgh, Pennsylvania (“National Union”) and Royal Insurance Company of America (“Royal”)(collectively “Defendant Insurers”) owed a duty to defend Knoll in the underlying case, In re Synthroid Mktg. Litig., 110 F.Supp.2d 676 (N.D.Ill.2000). On July 13, 2001, we partially granted Knoll’s motion for judgment on the pleadings and denied Defendant Insurers’ motions for judgment on the pleadings. (R. 60.) Further briefing was required to adjudicate the present issue, whether Defendant Insurers’ policies transferred as a matter of law to Knoll. This motion is being treated as Knoll’s motion for summary judgment. For the reasons set forth below, Knoll’s motion for summary judgment is granted. (R. 23-1.)

RELEVANT FACTS

We will assume familiarity with our pri- or opinion in this case, Knoll Pharm. Co. v. Auto. Ins. Co. of Hartford, Nat’l Union Fire Ins. Co. of Pittsburgh, PA and Royal Ins. Co. of Am., 152 F.Supp.2d 1026 (N.D.Ill.2001) (“Knoll J”), and wifi not needlessly repeat the facts not relevant to this motion.

Automobile issued Boots USA three insurance policies effective from 1989 to 1992. Royal issued Boots USA an insur- *1006 anee policy effective from 1992 to 1993. National Union issued Boots USA two insurance policies effective from September 1992 to December 1995. Id. at 1031. Although the substantive text of the policies contains identical language, the specific parties named under the policies (“named insureds”) vary. Coverage is provided to all parties listed in the policy as either named insured or additional insured. The policies, however, only grant the authority to transfer rights or cancel coverage to the first named insured. Boots Company PLC (“Boots PLC”) was neither a named insured nor an additional insured party in the policies at issue. 1 Furthermore, each policy contains a clause requiring the first named insured to obtain the written consent of the insurer in order to transfer the rights and duties under the policy. (R. 65, Auto.’s Mem. at 2; R. 64, Nat’l Union’s Mem. at 3; R. 66, Royal’s Mem. at 3.)

Boots USA and Knoll combined into one entity through two transactions. First, in March 1995, Boots PLC sold various assets to Basfin Corporation (“Basfin”) through an asset purchase agreement. 2 In this initial asset purchase agreement, Boots PLC sold all of the shares of Boots USA, as well as the Business Plant and Machinery, Business Stocks and the Business Goodwill, to Basfin. The sale of Boots USA’s shares included all rights attached to or accruing to these shares and provided for the name change to Knoll Pharmaceutical Company-B. Inc. 3 In addition, the asset purchase agreement contained specific provisions to guide the transfer of the seller’s contracts. Such contracts were defined as:

All the contracts and engagements relating exclusively to the Business or relating in part to the Business (but then only to the extent that the same do so relate) current at Completion to which the Seller is a party or the benefit of which is held in trust for or has been assigned to it but excluding: (i) all policies of insurance, past and present, relating to any aspect of the Business.

(R. 69, Pl.’s Reply Mem.,-App. B at 11.) The asset purchase agreement defined the “seller” as Boots PLC.

The second transaction combining Boots USA with Knoll Pharmaceutical Company was the April 1995 statutory merger of the two entities. (Id., App. F, Certificate of Merger.) After the merger, consumers filed several lawsuits, mostly class action, against Knoll regarding the sale and marketing of the prescription drug Synthroid between 1990 and 1997. The present case arose when Defendant Insurers denied that they had a duty to defend Knoll under their insurance policies. In Knoll I, we granted Knoll’s motion for judgment on the pleadings, finding that Defendant Insurers had a duty to defend Knoll because the allegations corresponded to and arose out of the covered offenses. We required further briefing, however, on the issue of whether the insurance policies transferred from Boots USA to Knoll through the transactions described above. In order to *1007 allow for the inclusion of materials outside the pleadings, we transformed Knoll’s motion for judgment on the pleadings to one for summary judgment. Presently before this Court is Knoll’s motion for summary judgment on the transferability of the policy rights.

STANDARD OF REVIEW

Summary judgment is appropriate “if the pleadings, depositions, answers to interrogatories, and admissions on file, together with the affidavits, if any, show that there is no genuine issue as to any material fact and that the moving party is entitled to a judgment as a matter of law.” Fed.R.Civ.P. 56(c). A genuine issue for trial exists only when “the evidence is such that a reasonable jury could return a verdict for the nonmoving party.” Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 248, 106 S.Ct. 2505, 91 L.Ed.2d 202 (1986). Accordingly, the nonmovant must “come forward with specific facts showing that there is a genuine issue for trial.” Miller v. Am. Family Mut. Ins. Co., 203 F.3d 997, 1003 (7th Cir.2000) (quoting Matsushita Elec. Indus. Co. v. Zenith Radio Corp., 475 U.S. 574, 587, 106 S.Ct. 1348, 89 L.Ed.2d 538 (1986)). It is not, however, the task of this Court to “scour the record” in search of a genuine issue, for we rely on the nonmoving party to identify “with reasonable particularity” the evidence that militates against summary judgment. Richards v. Combined Ins. Co. of Am., 55 F.3d 247, 251 (7th Cir.1995).

ANALYSIS

I. Transferability Through the Asset Purchase Agreement

Knoll maintains that the rights and duties under the insurance policies were unaffected by the initial asset purchase agreement that transferred the shares of Boots USA from Boots PLC to Basfin. (R. 69, Pl.’s Reply Mem. at 7.) Therefore, Knoll contends that the provisions in the agreement referring to the transfer of contractual obligations and liabilities are irrelevant to this matter and that the analysis should proceed to whether the insurance policies transferred through the subsequent merger with Knoll.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
167 F. Supp. 2d 1004, 2001 U.S. Dist. LEXIS 16382, 2001 WL 1195726, Counsel Stack Legal Research, https://law.counselstack.com/opinion/knoll-pharmaceutical-co-v-automobile-insurance-ilnd-2001.